GlassScriptPhysician profile
Gregory M Graves
NPI 1215351994
$4,715.34
in general payments reported to CMS, 2019-2025
13 companies · $655 in 2025
The $655 reported for 2025 was more than what 85% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $292 · 2022: $251 · 2023: $2,160 · 2024: $1,357 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,130 · Travel and Lodging: $905 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,130.36 |
| Travel and Lodging | $904.69 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,205.48 | 2021-2025 | Catalyft Pl Expandable Interbody System, Stealth Autoguide System, Unid_pass |
| Boston Scientific Corporation | $579.84 | 2021-2025 | General - Pain Management |
| Medical Device Business Services, INC. | $251.09 | 2023 | Stratafix |
| Nevro Corp. | $215.83 | 2021-2024 | Senza |
| Stryker Corporation | $182.01 | 2021-2024 | Cascadia Interbody System, Ozark Cervical Plate System, Canyon Retractor Systems |
| Highridge Medical LLC | $86.45 | 2024 | Vital |
| Zimmer Biomet Holdings, INC. | $42.79 | 2021 | |
| Pfizer INC. | $37.60 | 2021 | |
| Zimvie INC. | $28.64 | 2022 | |
| Davol INC. | $26.79 | 2022 | |
| Solventum Corporation | $25.36 | 2025 | Prevena |
| Abbott Laboratories | $17.26 | 2024 | Eterna |
| Baudax Bio INC. | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.